YAP1 and renal fibrosis: Further studies found that FXR agonists reduced the activity of the nonreceptor tyrosine kinase Src and prevented the nuclear translocation of YAP by phosphorylating YAP at Ser 127, ultimately blocking the progression of renal fibrosis.314